Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-48521

Samaras, P; Blickenstorfer, M; Haile, S R; Siciliano, D; Petrausch, U; Mischo, A; Zweifel, M; Honegger, H; Schanz, U; Stüssi, G; Taverna, C; Bauer, S; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience. Swiss Medical Weekly, 141:w13203.

Preview

Published Version
PDF
1390Kb

Abstract

ASCT is a safe and effective treatment mode in eligible patients with MM. TRM was below average at our institution. Achievement of CR after transplantation was the most valuable predictor for improved overall survival.

Item Type:	Journal Article, refereed, original work
Communities & Collections:	04 Faculty of Medicine > University Hospital Zurich > Clinic for Hematology 04 Faculty of Medicine > Institute of Social and Preventive Medicine 04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
DDC:	610 Medicine & health
Language:	English
Date:	2011
Deposited On:	28 Jun 2011 10:56
Last Modified:	11 Jan 2013 08:32
Publisher:	EMH Swiss Medical Publishers
ISSN:	0036-7672
Publisher DOI:	10.4414/smw.2011.13203
PubMed ID:	21630163

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page